Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

NCT02242643

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 66 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

NCT01884519

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Freiberg, Saxony, Germany
  • GSK Investigational Site Freital, Saxony, Germany
  • GSK Investigational Site Schmiedeberg, Saxony, Germany
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older

NCT01878812

Conditions
Infections, Influenza, Influenza, Human, +5 more
Locations
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
  • GSK Investigational Site Dresden, Saxony, Germany
View Trial Details

Related conditions